08-01-2018 04:16 PM CET - Advertising, Media Consulting, Marketing Research
Print

Cancer Tumor Profiling Market By Top Vendors (Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp.) and Global Forecast

Press release from: Data Bridge Market Research
Global Cancer Tumor Profiling Market
Global Cancer Tumor Profiling Market


The report gives inside and industry Outlook on global cancer tumor profiling market. It helps in imagining the arrangement of the global cancer tumor profiling market complete analysis regarding type and applications, featuring the key business resources and key players. Global cancer tumor profiling market development divisions and distinguishes factors driving change. This Research helps in understanding the dynamic condition, market’s significant players, and driving brands. The global cancer tumor profiling market five-year period can evaluate how the market is forecast to evolve. This analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimate forecast frame. Recognize the most recent global cancer tumor profiling market improvements, share, and systems utilized by the significant market.

Global Cancer Tumor Profiling Market accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Download Free Sample Report Copy@ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Cancer Tumor Profiling Market studies the size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the Global Cancer Tumor Profiling Market by companies, region, type and end-use industry.

Major Market Competitors:

Some of the major players operating in global cancer tumor profiling market are

• Helomics Corp.,
• NanoString Technologies, Inc.,
• Oxford Gene Technology,
• Abbott,
• BD,
• Illumina, Inc.,
• Qiagen N.V.,
• F. Hoffmann-La Roche AG,
• NeoGenomics Laboratories, Inc.,
• HTG Molecular Diagnostics, Inc.,
• Genomic Health Inc. ,
• Caris Life Sciences,
• Hologic, Inc.,
• Siemens Medical Solutions USA Inc.,
• Personal Genome Diagnostics, Inc.,
• FOUNDATION MEDICINE, INC.,
• Contextual Genomics,
• AGENDIA,
• Perthera, Inc.,
• ApoCell,
• GenScript,
• Ribomed,
• Boreal Genomics Inc.,
• Biotheranostics and
• Proteome Sciences among others.

Major Market Drivers and Restraints:

• Technological advancements for identifying the cancer tumors.
• Increasing the cancer incidences.
• Increase in demand for next generation sequencing technique in cancer profiling.
• Lack of Skilled Professionals and Infrastructure
• Growth in demand of personalized medicines
• Increase in the use of biomarkers in tumor profiling.
• Availability of Funding for Cancer Research

To Avail 10% Discount On This Report Mail Us:- sopan.gedam@databridgemarketresearch.com

Competitive Analysis:

The global cancer tumor profiling market is fragmented with the presence of a large number of players across different regions. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Market Segmentation:

The global cancer tumor profiling market is segmented by technology into:-

• Next-Generation Sequencing,
• Polymerase Chain Reaction,
• Immunohistochemistry,
• In Situ Hybridization and Microarray.
o Fluorescence In Situ Hybridization And
o Chromogenic In Situ Hybridization.

By Application the market is segmented into:-

• Personalized Medicine,
• Diagnostics,
• Biomarker Discovery,
• Prognostics and
• Research Applications.

By Technique the market is segmented in:-

• Genomics,
• Proteomics,
• Epigenetics and
• Metabolomics.

Inquiry Before buying: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1157514 • Views: 830
More releasesMore releases

You can edit or delete your press release here: